Pazopanib, a novel multi-targeted kinase inhibitor shows potent in vitro antitumor activity in gastric cancer cell lines harboring FGFR2 amplification, which is a potential therapeutic target in gastric cancer.
구분
국외
국가
미국
컨퍼런스명
Molecular Targets and Cancer Therapeutics
발표 제목
Pazopanib, a novel multi-targeted kinase inhibitor shows potent in vitro antitumor activity in gastric cancer cell lines harboring FGFR2 amplification, which is a potential therapeutic target in gastric cancer.